SPAC Update – March 1

– CMCA announced a business combination with Lexasure Financial Group
– VHAQ announced a letter of intent to merge with Clearday
– TPBA / LVRO deal closed, minimum cash condition waived
– TBSA to liquidate Mar 13, NAV $10.17
– ACQR to liquidate Mar 10, NAV $10.20
– AGAC announced 37.3 million shares (90.1%) redeemed, 4.1 million shares remain
– HPX stockholders approved Ambipar Response deal, 1.3 million shares (57.8%) redeemed, 918k shares remain, closing Mar 3
– EBAC stockholders approved Oculis SA deal, 11.5 million shares (90.2%) redeemed, 1.2 million shares remain, closing Mar 2
– CCAI stockholders approved deadline extension to Aug 31 2023, 14.7 million shares (98.1%) redeemed, 289k shares remain
– FEXD filed PRE14a to extend deadline to Apr 21 2024, trust account will not be used to cover potential excise tax, NAV $10.48
– JMAC filed DEFM14a for Apollomics deal, vote Mar 20, NAV $10.55
– IVCB filed DEF14a to extend deadline to Dec 17 2023, vote Mar 14, NAV $10.38
– JATT filed 424b3 for Zura Bio deal, vote Mar 16
– REVE deal vote adjourned to Mar 16
– OXUS adjourned extension vote to Mar 2
– ATAQ extension vote
– CMCA extension vote
– NSTD extension vote
– NSTC extension vote
– PIAI redemption
– FRXB redemption
– DHCA redemption
– DMYS redemption